Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04978727
Title A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pediatric Brain Tumor Consortium
Indications

anaplastic ependymoma

glioblastoma

benign ependymoma

malignant astrocytoma

oligodendroglioma

diffuse midline glioma, H3 K27M-mutant

anaplastic astrocytoma

medulloblastoma

Therapies

SurVaxM

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.